Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.
Clinical trial NCT06982534 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06982534
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.